Kupchyk Areta 4
4 · Anebulo Pharmaceuticals, Inc. · Filed Oct 3, 2022
Insider Transaction Report
Form 4
Kupchyk Areta
Director
Transactions
- Award
Stock Option (right to buy)
2022-04-21+30,425→ 30,425 totalExercise: $6.00Exp: 2027-02-28→ Common Stock (30,425 underlying)
Footnotes (1)
- [F1]25% of the option vests on March 1, 2023. Thereafter, 1/48 of the option vests on a monthly basis over 36 months until the option becomes fully vested.